COMPOUNDS FOR CANCER TREATMENT

MA71293A1Pending Publication Date: 2026-06-30GENESIS THERAPEUTICS INC
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
MA71293
Authority / Receiving Office
MA · MA
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-09-11
Filing Date
2023-09-11
Publication Date
2026-06-30
Patent Text Reader

Abstract

The present invention relates to compounds of formula (A), as defined in the description, and pharmaceutically acceptable salts thereof, as well as methods for preparing compounds of formula (A) and pharmaceutically acceptable salts thereof. The present invention also relates to a pharmaceutical composition comprising a compound of formula (A) and pharmaceutically acceptable salts thereof, and to methods for using the compounds and compositions for the treatment of diseases, such as cancer.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Cdk inhibiting pyrimidines, production thereof and their use as medicaments

    WO2002096888A1

  • Disubstituted cyclopentane kinase inhibitors

    WO2022135365A1